Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.[E12]

Extrait de l’avis

Titre : Demande de propositions (DP) pour des tests pharmacologiques sur de nouveaux stimulants et cannabinoïdes synthétiques. Amended Request For Proposal (RFP) for Pharmacological testing of stimulants, and synthetic cannabinoids. Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments. The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their harms to Canadians. This procurement activity will allow for the evaluation of the in vitro pharmacological activity of two categories of emerging drugs: synthetic cannabinoids, and stimulants. The data generated from this contract will inform future assessment activities and allow the OLRA to make more informed regulatory science decisions. For both streams, they require the pharmacological testing of different classes of substances, and require acquisition of reference standards and control samples, getting licenses for controlled substances, conducting experiments (including doing statistical analysis), and finally drafting and finalizing reports. Canada is seeking offers from Offerors to provide Pharmacological Testing for Stimulants, and Synthetic Cannabinoids in two (2) separate streams to Health Canada. Stream 2 – In vitro pharmacological testing of novel…[E5]

Les détails de l’avis sont affichés tels que la source les a publiés. Les faits et exigences que nous extrayons sont rédigés en anglais.

• ConditionDelivery regions: National Capital Region (NCR).[E6]
• ConditionTrade agreements that apply: North American Free Trade Agreement (NAFTA); Canada-Korea Free Trade Agreement (CKFTA).[E7]

• InconnuThe notice does not state a value.
• InconnuWe read the published notice, not the full tender documents.

1. Vu pour la première fois · 28 oct. 2026, 13:27 UTC

   The source published a call for competition with a future deadline.

   Document source cb-912-87371785@000@Open

Chaque information de cette page provient de l’avis publié. Chaque entrée indique le document et le champ dont elle a été lue.

1. E1

   The buyer is Department of Health (HC).

   Document cb-912-87371785@000@Open, champ /contractingEntityName-nomEntitContractante-eng, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

2. E2

   The notice is classified under UNSPSC 51000000 (Drugs and Pharmaceutical Products).

   Document cb-912-87371785@000@Open, champ /unspsc, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

3. E3

   CanadaBuys publishes Government of Canada tenders.

   “CA”

   Document cb-912-87371785@000@Open, champ /contractingEntityName-nomEntitContractante-eng, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

4. E4

   Bids close at (Eastern Time assumed: the open data states no zone) 9 Nov 2026, 17:00 GMT-5.

   “2026-11-09T17:00:00”

   Document cb-912-87371785@000@Open, champ /tenderClosingDate-appelOffresDateCloture, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

5. E5

   The buyer describes the requirement in the notice.

   “Amended Request For Proposal (RFP) for Pharmacological testing of stimulants, and synthetic cannabinoids. Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs incr…”

   Document cb-912-87371785@000@Open, champ /tenderDescription-descriptionAppelOffres-eng, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

6. E6

   Delivery regions: National Capital Region (NCR).

   Document cb-912-87371785@000@Open, champ /regionsOfDelivery-regionsLivraison-eng, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

7. E7

   Trade agreements that apply: North American Free Trade Agreement (NAFTA); Canada-Korea Free Trade Agreement (CKFTA).

   Document cb-912-87371785@000@Open, champ /tradeAgreements-accordsCommerciaux-eng, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

8. E8

   This is a Request for Proposal on CanadaBuys.

   Document cb-912-87371785@000@Open, champ /noticeType-avisType-eng, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

9. E9

   The procurement method is Competitive - Open bidding.

   Document cb-912-87371785@000@Open, champ /procurementMethod-methodeApprovisionnement-eng, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

10. E10

    The notice was published on 27 Oct 2026.

    “2026-10-27”

    Document cb-912-87371785@000@Open, champ /publicationDate-datePublication, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

11. E11

    CanadaBuys gives the status as Open.

    Document cb-912-87371785@000@Open, champ /tenderStatus-appelOffresStatut-eng, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

12. E12

    The notice is titled "Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.".

    Document cb-912-87371785@000@Open, champ /title-titre-eng, lu 28 oct. 2026, 13:27 UTC · source ↗ (s’ouvre dans un nouvel onglet)

Contains information licensed under the Open Government Licence – Canada (CanadaBuys). Licence des données : Open Government Licence – Canada 2.0 ↗ (s’ouvre dans un nouvel onglet). Les coordonnées personnelles figurant dans les avis ne sont ni conservées ni affichées.